Application of digital tools and artificial intelligence in the Myasthenia Gravis Core Examination
- PMID: 39697445
- PMCID: PMC11652356
- DOI: 10.3389/fneur.2024.1474884
Application of digital tools and artificial intelligence in the Myasthenia Gravis Core Examination
Abstract
Background: Advances in video image analysis and artificial intelligence provide opportunities to transform how patients are evaluated. In this study, we assessed the ability to quantify Zoom video recordings of a standardized neurological examination- the Myasthenia Gravis Core Examination (MG-CE)-designed for telemedicine evaluations.
Methods: We used Zoom (Zoom Video Communications) videos of patients with myasthenia gravis (MG) who underwent the MG-CE. Computer vision, in combination with artificial intelligence methods, was used to develop algorithms to analyze the videos, with a focus on eye and body motions. To assess the examinations involving vocalization, signal processing methods, such as natural language processing (NLP), were developed. A series of algorithms were developed to automatically compute the metrics of the MG-CE.
Results: A total of 51 patients with MG were assessed, with videos recorded twice on separate days, while 15 control subjects were evaluated once. We successfully quantified the positions of the lids, eyes, and arms and developed respiratory metrics based on breath counts. The cheek puff exercise was found to have limited value for quantification. Technical limitations included variations in illumination, bandwidth, and the fact that the recording was conducted from the examiner's side rather than the patient's side.
Conclusion: Several aspects of the MG-CE can be quantified to produce continuous measurements using standard Zoom video recordings. Further development of the technology will enable trained non-physician healthcare providers to conduct precise examinations of patients with MG outside of conventional clinical settings, including for the purpose of clinical trials.
Keywords: clinical trial; computer vision; deep learning; diplopia; myasthenia gravis; neurological disease; ptosis; telehealth.
Copyright © 2024 Garbey, Lesport, Girma, Öztosun, Abu-Rub, Guidon, Juel, Nowak, Soliven, Aban and Kaminski.
Conflict of interest statement
MG is CEO of Care Constitution Corp. and has patents pending related to present technology. HK is a consultant for Roche, Takeda, Cabaletta Bio, UCB Pharmaceuticals, Canopy Immunotherapeutics, EMD Serono, Ono Pharmaceuticals, ECoR1, Gilde Healthcare, and Admirix, Inc. Argenix provides an unrestricted educational grant to George Washington University. He is an unpaid consultant for Care Constitution. HK has equity interest in Mimivax, LLC. He is supported by NIH U54 NS115054. QL was employed by Care Constitution Corp. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Update of
-
Application of Digital Tools and Artificial Intelligence to the Myasthenia Gravis Core Examination.medRxiv [Preprint]. 2024 Jul 19:2024.07.19.24310691. doi: 10.1101/2024.07.19.24310691. medRxiv. 2024. Update in: Front Neurol. 2024 Dec 04;15:1474884. doi: 10.3389/fneur.2024.1474884. PMID: 39072011 Free PMC article. Updated. Preprint.
Similar articles
-
A Quantitative Study of Factors Influencing Myasthenia Gravis Telehealth Examination Score.Muscle Nerve. 2025 Jul;72(1):34-41. doi: 10.1002/mus.28394. Epub 2025 Apr 2. Muscle Nerve. 2025. PMID: 40176335
-
Application of Digital Tools and Artificial Intelligence to the Myasthenia Gravis Core Examination.medRxiv [Preprint]. 2024 Jul 19:2024.07.19.24310691. doi: 10.1101/2024.07.19.24310691. medRxiv. 2024. Update in: Front Neurol. 2024 Dec 04;15:1474884. doi: 10.3389/fneur.2024.1474884. PMID: 39072011 Free PMC article. Updated. Preprint.
-
A Digital Telehealth System to Compute the Myasthenia Gravis Core Examination Metrics.JMIR Neurotechnol. 2023;2:e43387. doi: 10.2196/43387. Epub 2023 Apr 19. JMIR Neurotechnol. 2023. PMID: 37435094 Free PMC article.
-
Open source modular ptosis crutch for the treatment of myasthenia gravis.Expert Rev Med Devices. 2018 Feb;15(2):137-143. doi: 10.1080/17434440.2018.1421455. Epub 2018 Jan 15. Expert Rev Med Devices. 2018. PMID: 29271663 Review.
-
Application Prospect of Artificial Intelligence in Rehabilitation and Management of Myasthenia Gravis.Biomed Res Int. 2021 Mar 4;2021:5592472. doi: 10.1155/2021/5592472. eCollection 2021. Biomed Res Int. 2021. PMID: 33763475 Free PMC article. Review.
Cited by
-
Construction of patient trajectories to model clinical trial outcomes: Application to Myasthenia Gravis.medRxiv [Preprint]. 2025 Apr 16:2025.04.11.25325663. doi: 10.1101/2025.04.11.25325663. medRxiv. 2025. PMID: 40321274 Free PMC article. Preprint.
-
Machine Learning in Myasthenia Gravis: A Systematic Review of Prognostic Models and AI-Assisted Clinical Assessments.Diagnostics (Basel). 2025 Aug 14;15(16):2044. doi: 10.3390/diagnostics15162044. Diagnostics (Basel). 2025. PMID: 40870896 Free PMC article. Review.
-
A Quantitative Study of Factors Influencing Myasthenia Gravis Telehealth Examination Score.Muscle Nerve. 2025 Jul;72(1):34-41. doi: 10.1002/mus.28394. Epub 2025 Apr 2. Muscle Nerve. 2025. PMID: 40176335
-
Recent Advances in Diagnosis, Management, Treatment, and Prevention of Neuropathies in Cancer Patients.Curr Neurol Neurosci Rep. 2025 Jun 20;25(1):42. doi: 10.1007/s11910-025-01429-3. Curr Neurol Neurosci Rep. 2025. PMID: 40540116 Review.
-
Bridging the Heterogeneity of Myasthenia Gravis Severity Scores for Digital Twin Development.medRxiv [Preprint]. 2025 Jun 13:2025.06.13.25329566. doi: 10.1101/2025.06.13.25329566. medRxiv. 2025. PMID: 40585131 Free PMC article. Preprint.
References
LinkOut - more resources
Full Text Sources